OraSure Technologies, Inc. (OSUR)
NASDAQ: OSUR · Real-Time Price · USD
3.430
-0.060 (-1.72%)
At close: Mar 28, 2025, 4:00 PM
3.485
+0.055 (1.59%)
After-hours: Mar 28, 2025, 7:50 PM EDT
OraSure Technologies Market Cap
OraSure Technologies has a market cap or net worth of $256.56 million as of March 28, 2025. Its market cap has decreased by -50.76% in one year.
Market Cap
256.56M
Enterprise Value
3.41M
1-Year Change
-50.76%
Ranking
Category
Stock Price
$3.43
Market Cap Chart
Since December 1, 1998, OraSure Technologies's market cap has increased from $72.90M to $256.56M, an increase of 251.94%. That is a compound annual growth rate of 4.89%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2025 | 261.10M | -3.04% |
Dec 31, 2024 | 269.30M | -55.31% |
Dec 29, 2023 | 602.60M | 72.17% |
Dec 30, 2022 | 350.00M | -44.09% |
Dec 31, 2021 | 626.00M | -17.56% |
Dec 31, 2020 | 759.30M | 53.18% |
Dec 31, 2019 | 495.70M | -30.71% |
Dec 31, 2018 | 715.40M | -37.45% |
Dec 29, 2017 | 1.14B | 133.76% |
Dec 30, 2016 | 489.30M | 34.53% |
Dec 31, 2015 | 363.70M | -36.01% |
Dec 31, 2014 | 568.40M | 62.54% |
Dec 31, 2013 | 349.70M | -11.76% |
Dec 31, 2012 | 396.30M | -7.88% |
Dec 30, 2011 | 430.20M | 61.85% |
Dec 31, 2010 | 265.80M | 13.93% |
Dec 31, 2009 | 233.30M | 38.21% |
Dec 31, 2008 | 168.80M | -59.27% |
Dec 31, 2007 | 414.40M | 9.17% |
Dec 29, 2006 | 379.60M | -5.45% |
Dec 30, 2005 | 401.50M | 34.10% |
Dec 31, 2004 | 299.40M | -14.36% |
Dec 31, 2003 | 349.60M | 70.87% |
Dec 31, 2002 | 204.60M | -54.74% |
Dec 31, 2001 | 452.10M | 50.80% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 738.61B |
UnitedHealth Group | 472.03B |
Johnson & Johnson | 394.52B |
AbbVie | 363.15B |
Novo Nordisk | 305.46B |
AstraZeneca | 229.16B |
Abbott Laboratories | 226.88B |
Merck & Co. | 225.40B |